Abbott's MitraClip gets a date with the FDA

February 15, 2013 by MassDevice staff

The FDA's Circulatory System Devices Panel will review data and make recommendations on Abbott's MitraClip aortic valve repair system.

Abbott's MitraClip device

Abbott (NYSE:ABT) landed an FDA panel date to review its MitraClip aortic valve repair system, according to an FDA notice.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp